- Home
- IPHA vs ENX Comparison
IPHA vs ENX Comparison
Compare IPHA & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- ENX
- Stock Information
- Founded
- IPHA 1999
- ENX 2002
- Country
- IPHA France
- ENX United States
- Employees
- IPHA N/A
- ENX N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- ENX Finance/Investors Services
- Sector
- IPHA Health Care
- ENX Finance
- Exchange
- IPHA Nasdaq
- ENX Nasdaq
- Market Cap
- IPHA 171.6M
- ENX 178.4M
- IPO Year
- IPHA 2019
- ENX N/A
- Fundamental
- Price
- IPHA $2.25
- ENX $9.87
- Analyst Decision
- IPHA Strong Buy
- ENX
- Analyst Count
- IPHA 1
- ENX 0
- Target Price
- IPHA $11.50
- ENX N/A
- AVG Volume (30 Days)
- IPHA 6.4K
- ENX 25.4K
- Earning Date
- IPHA 09-12-2024
- ENX 01-01-0001
- Dividend Yield
- IPHA N/A
- ENX 3.94%
- EPS Growth
- IPHA N/A
- ENX N/A
- EPS
- IPHA N/A
- ENX 0.16
- Revenue
- IPHA $36,202,722.00
- ENX N/A
- Revenue This Year
- IPHA N/A
- ENX N/A
- Revenue Next Year
- IPHA $105.84
- ENX N/A
- P/E Ratio
- IPHA N/A
- ENX $61.00
- Revenue Growth
- IPHA N/A
- ENX N/A
- 52 Week Low
- IPHA $1.81
- ENX $7.84
- 52 Week High
- IPHA $3.15
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- IPHA 49.51
- ENX 42.06
- Support Level
- IPHA $2.07
- ENX $9.95
- Resistance Level
- IPHA $2.29
- ENX $10.08
- Average True Range (ATR)
- IPHA 0.10
- ENX 0.07
- MACD
- IPHA -0.01
- ENX -0.00
- Stochastic Oscillator
- IPHA 52.85
- ENX 4.35
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.